about
Eculizumab and renal transplantation in a patient with CAPSApoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREBA nitric oxide signaling pathway controls CREB-mediated gene expression in neuronsMitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survivalFunction and regulation of CREB family transcription factors in the nervous systemQuantifying renal allograft loss following early antibody-mediated rejection.A model for neuronal competition during development.Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.Stem cell mobilization is life saving in an animal model of acute liver failure.Operative start times and complications after liver transplantation.Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients.Operative start times and complications after kidney transplantation.Histocompatibility and management of the highly sensitized kidney transplant candidate.Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under-recognized syndrome.Individual Frailty Components and Mortality in Kidney Transplant Recipients.Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study.Where the Sun Shines: Industry's Payments to Transplant Surgeons.Kidney transplantation in previous heart or lung recipients.Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants.In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression.Outcomes and discard of kidneys from pediatric donors after cardiac death.Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.Nontraditional sites for vascular anastomoses to enable kidney transplantation in patients with major systemic venous thromboses.Successful Renal Transplantation of Deceased Donor Kidneys With 100% Glomerular Fibrin Thrombi and Acute Renal Failure Due to Disseminated Intravascular Coagulation.Transgene expression in zebrafish: A comparison of retroviral-vector and DNA-injection approaches.Pre-transplant screening for non-HLA antibodies: Who should be Tested?Desensitization in HLA-incompatible kidney recipients and survival.A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling.Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome.IgG Degrading Enzyme of Streptococcus Pyogenes: An Exciting New Development in Desensitization Therapy.Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection.Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.IdeS (Imlifidase)Repeat A2 into B kidney transplantation after failed prior A2 into B transplant: A Case ReportSurgical management of early and late ureteral complications after renal transplantation: techniques and outcomesEculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney TransplantationHistologic Phenotype on 1-Year Posttransplantation Biopsy and Allograft Survival in HLA-Incompatible Kidney TransplantsEculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation
P50
Q28281405-BE39F83A-AA36-4B0F-A3E8-2910D0C5CB15Q28505126-24DED689-93F9-49BE-9FB2-1ACF9D6D880BQ28510057-F40F52C5-27A8-4937-8310-616863A0B777Q28580488-97955CC9-D52E-4C00-BEA0-90BDB85B6029Q29619559-5CA272A6-F123-4B6B-BD6C-D4A709CDD873Q35007419-D8607733-C261-411A-98FE-EF2E45F1A99EQ36728766-60813CD8-E22F-491C-86DA-B60DE6477BE0Q36827985-2A5A5786-F4F3-4CD0-90CF-9CACFF1CE392Q37616117-DEA6238D-004E-44B8-9A32-B3A794166C28Q37775689-19617423-4C51-4F09-AE51-5DEC5F658670Q37888429-ED47B8A8-536C-4FDE-B575-1510A758C661Q38007970-70A69C42-A884-4AAF-AC3C-5107F03AD825Q38686432-5A3E44F3-542B-41C6-9CD1-14771519E5B7Q40245497-A09F3BC6-FB76-47A8-B88C-DC61F0AB3D6AQ40340737-4A11F537-AA89-4633-9EBB-6F39BBF31698Q40517132-25BA3591-F67A-4FD6-A86C-92001B027C06Q40571062-F0BC5706-2A68-486B-B99A-2D4DFEB4C2A1Q40596702-793FDAC7-4658-493E-9D2D-FAD5CB411A27Q42613920-1536EE5A-1B6E-42AD-8EFB-76380D12A4C2Q42615403-7C27EA8B-D209-4036-8E64-102FF86689F2Q42979423-D97651B4-1147-4F39-A6B8-B157AFE3EB2AQ45719001-5FD65D10-88DD-4EB1-B38D-5EDF635DB75BQ47194132-CB89BAF8-9760-4435-87ED-C6955789D7A1Q47927050-4067FDF1-AE72-4081-81F1-284B7B9B9A6AQ48272177-84ECB900-090B-473C-988A-38ECE2CF8646Q48588023-6BB29EA4-6EA3-4B3E-8763-9E20EEA3800DQ48910622-1665EAA2-50B9-46B5-BC9A-BF67C976EA3BQ50049252-98D6BB70-FD22-41BF-BA35-F3AC4A19723FQ51018759-81B6C493-6732-48F5-ACAC-AB98EE895A4BQ52088593-CFF00991-3BB9-4004-AD97-34717DD5A650Q52624119-7580AF02-A24C-4FF0-960E-F4FA45E41F69Q52738922-AA84C65C-A178-462E-A795-E7D5B65EFCABQ53096184-CF88305B-B458-4598-AAFC-5FABF7D30689Q53363804-AB60BD12-65A6-4C6C-A15F-0979760890A1Q58048124-C084E71A-61AE-4CB5-B847-0230ECACFF7FQ58048128-031A2119-A9D4-4AF8-AB02-58BDC148FA92Q58048133-235BF676-15FF-4AD0-BEF4-5F438031B80BQ58048136-D9AFD917-DBBB-4986-8D2E-2EDF1DE79615Q58048137-4F09E701-ADB1-4100-A6DA-9494A37E9DA2Q58048140-F016ADC1-BB47-4B05-A5D7-F8F9CC57B9AB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bonnie E. Lonze
@ast
Bonnie E. Lonze
@en
Bonnie E. Lonze
@es
Bonnie E. Lonze
@nl
Bonnie E. Lonze
@sl
type
label
Bonnie E. Lonze
@ast
Bonnie E. Lonze
@en
Bonnie E. Lonze
@es
Bonnie E. Lonze
@nl
Bonnie E. Lonze
@sl
prefLabel
Bonnie E. Lonze
@ast
Bonnie E. Lonze
@en
Bonnie E. Lonze
@es
Bonnie E. Lonze
@nl
Bonnie E. Lonze
@sl
P106
P1153
55179016800
6506216825
P21
P31
P496
0000-0002-0973-1657